Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

This study is ongoing, but not recruiting participants.

Study NCT00001254. Last updated on July 18, 2008. Information provided by National Institutes of Health Clinical Center (CC)

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields
Brief Title ^†	Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
Official Title ^†	Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome
Brief Summary	This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.
Detailed Description	This protocol concerns the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.
Study Phase
Study Type ^†	Observational
Study Design ^†
Primary Outcome Measure ^†
Secondary Outcome Measure ^†
Condition ^†	Gastrinoma Zollinger Ellison Syndrome
Intervention ^†
MEDLINE PMIDs	3309661, 2686566, 45919
Links	NIH Clinical Center Detailed Web Page

Recruitment Information Fields
Recruitment Status ^†	Active, not recruiting
Enrollment ^†	999
Start Date ^†	May 1990
Completion Date
Eligibility Criteria ^†	INCLUSION CRITERIA: New patients will be evaluated initially as described in the protocol entitled, "Diagnostic evaluation of patients with suspected abnormalities of gastric secretion" (89-DK-0005). Only those patients that are being treated under the protocol entitled, "Medical Therapy of Zollinger-Ellison Syndrome" (protocol # 89-DK-0015) will be entered into this tumor localization and management protocol.
Gender	Both
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^††
Location Countries ^†	United States

Administrative Information Fields
NCT ID ^†	NCT00001254
Organization ID	900137
Secondary IDs ^††	90-DK-0137
Study Sponsor ^†	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators ^††
Investigators ^†
Information Provided By	National Institutes of Health Clinical Center (CC)
Verification Date	March 2008
First Received Date ^†	November 3, 1999
Last Updated Date	July 18, 2008

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.